Online pharmacies in the UK make money primarily through the margin on prescription medicines they dispense — plus consultation fees, OTC product sales, and (for some) advertising or platform fees. The unit economics work when patient acquisition cost is below the lifetime margin contribution, and when operational overhead scales sub-linearly with patient volume. This piece walks through the actual money flows.
The four revenue streams
Stream one: medicine margin. The pharmacy buys medicines wholesale and sells them at a marked-up patient price. Margin depends on category — branded medicines often have thinner margins, generics and category-leader products can carry higher margins. Typical gross margin ranges 20-50% on the medicine itself.
Stream two: dispensing fees. The operational cost of dispensing is recovered through a per-dispense fee, typically £4-£15 depending on category, SLA, and complexity. Stream three: consultation fees (if unbundled from the prescription) — £15-£75 typical, higher for specialist consultations. Stream four: OTC products, wellness ranges, and adjacent commerce — usually a smaller share but useful for AOV.
The cost side — what eats the margin
Patient acquisition cost (CAC) is the largest variable cost for most UK online pharmacies. Typical UK CAC ranges £40-£200 depending on category, competition, and channel mix. Categories with high competition (HRT, ED, hair loss) sit at the higher end; less-saturated categories at the lower end.
Operational costs include: clinician time (consultation), pharmacist time (dispensing clinical check), pharmacy technician and assistant time, identity verification per patient, payment processing fees, courier costs, customer support, technology infrastructure, and compliance overhead. These typically aggregate to £15-£40 per fulfilled order beyond the medicine itself.
The lifetime value calculation
Patient lifetime value (LTV) is what determines whether the unit economics work. If patient acquisition costs £100 and the patient makes one £40-margin purchase, the unit economics are negative. If the same patient buys 8 times over 12 months at £40 margin each (£320 lifetime margin), the unit economics work after the first repeat.
Categories with strong repeat patterns (HRT, ED, chronic disease maintenance) have favourable LTV economics. Single-purchase categories (acute STI treatment, emergency contraception) need a lower CAC to be unit-economic. The category choice is foundational to whether the business can profitably exist.
Why scale changes the maths meaningfully
Fixed costs (clinical governance, regulatory compliance, technology infrastructure, brand presence) don't scale linearly with patient volume. The first 1,000 patients carry the full fixed-cost burden; the next 10,000 share the same fixed cost across a larger base. This is why scale matters for unit economics.
The implication: early-stage operators often run at a loss on unit economics because the fixed costs dominate. The maturity question is whether the business can reach scale before runway runs out. This is the central financing question for any UK online pharmacy.
Where the platform/partnership decision affects unit economics
Operators who build everything in-house carry the full fixed cost themselves — heavy in early stage, leverageable at scale. Operators who partner with white-label platforms convert fixed cost into variable cost (per-dispense fees instead of pharmacy overhead) — lighter in early stage, less leverageable at scale.
The decision affects when and how the unit economics turn positive. White-label partners like PExpo are often the right choice through year 1-3 of an operator's journey, with the build-it-yourself option becoming attractive at scale where the variable cost would otherwise dominate.
How PExpo affects the unit economics for white-label brands
PExpo's brand model converts the regulated layer (clinical workflow, prescribers, dispensing, pharmacovigilance) from a £600k-£1.5m fixed-cost build into a per-dispense variable cost. For a brand at 200-500 patients per month, this dramatically improves early-stage unit economics. At 5,000+ per month, the calculation becomes more nuanced — but most brands don't need to revisit it until they're well into scaling.
See our brand model page for the operational scope and our pricing page for the commercial structure that affects unit economics directly.
Patient lifetime value (LTV) versus customer acquisition cost (CAC) is the foundational unit-economics calculation for a UK online pharmacy. Categories with strong repeat patterns (HRT, ED, chronic disease) have favourable LTV economics. Single-purchase categories need lower CAC to be sustainable.
Early-stage operators often run at a loss on unit economics because fixed costs dominate. The maturity question is whether the business can reach scale before runway runs out.
UK online pharmacies make money through medicine margin, dispensing fees, consultation fees, and adjacent commerce. The unit economics work when LTV exceeds CAC and scale dilutes fixed costs. Founders who understand the maths build sustainable businesses. The ones who chase revenue without measuring the underlying economics burn through capital. See our brand model page for the partnership infrastructure or our pricing page for the commercial structure.
Frequently asked questions
What gross margin do UK online pharmacies make on prescription medicines?
Typically 20-50% gross margin on the medicine itself, varying by category. Branded medicines often have thinner margins; generics and category-leader products can carry higher margins. Plus dispensing fees layered on top.
How much does it cost to acquire a UK telehealth patient?
UK CAC ranges £40-£200 depending on category, competition, and channel mix. Categories with high competition (HRT, ED, hair loss) sit at the higher end.
Does partnering with PExpo improve unit economics?
For early-stage brands, yes — it converts the regulated-layer fixed cost into variable cost, dramatically improving early-stage unit economics. At higher scale, the calculation becomes more nuanced. See our brand model page.
